Literature DB >> 30287154

Mechanisms underlying select chemotherapeutic-agent-induced neuroinflammation and subsequent neurodegeneration.

Fleur McLeary1, Arie Davis1, Santosh Rudrawar1, Anthony Perkins2, Shailendra Anoopkumar-Dukie3.   

Abstract

This review demonstrates the importance of uncovering the mechanisms that underlie chemotherapy-induced neuroinflammation. It builds upon the well-established connection between chemotherapeutic-agents and neurotoxicity along with widespread peripheral toxicities. This article summarises the major studies which have linked chemotherapy-induced neurodegeneration with direct evidence of neuroinflammation. Cancer and chemotherapy-related adverse effects impact a large proportion of the population. A better understanding of the link between chemotherapy, neurotoxicity and specifically the mechanisms of neuroinflammation, will allow the development of strategies to improve the management of side effects, and overall to reduce the burden on cancer patients receiving chemotherapy. This review has developed a summary schematic of the relationship between different chemotherapeutic agents and inflammatory markers within the central nervous system and links this correlation with some major ailments associated with chemotherapy use.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Chemotherapeutic agents; Chemotherapy; Neurodegeneration; Neuroinflammation; Neurotoxicity

Mesh:

Substances:

Year:  2018        PMID: 30287154     DOI: 10.1016/j.ejphar.2018.09.034

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  An infection of Enterobacter ludwigii affects development and causes age-dependent neurodegeneration in Drosophila melanogaster.

Authors:  Subhashree Priyadarsini; Moumita Sahoo; Swetapadma Sahu; Rasu Jayabalan; Monalisa Mishra
Journal:  Invert Neurosci       Date:  2019-10-22

2.  The effect of doxorubicin or cyclophosphamide treatment on auditory brainstem response in mice.

Authors:  Maxwell Hennings; Thane Fremouw
Journal:  Exp Brain Res       Date:  2022-09-19       Impact factor: 2.064

3.  Synergistic Antinociceptive Effects of Indomethacin-Pregabalin and Meloxicam-Pregabalin in Paclitaxel-Induced Neuropathic Pain.

Authors:  Yurong Ma; Wenwen Liu; Lingzhi Liang; Jiaqi Ye; Chaonan Huang; Tao Zhuang; Guisen Zhang
Journal:  Biomedicines       Date:  2022-06-15

Review 4.  Visual Pathway Degeneration in Chemotherapy-Related Neurotoxicity: A Review and Directions for Future Research.

Authors:  David E Anderson; Sarah A Holstein; Sachin Kedar
Journal:  Neuroophthalmology       Date:  2020-01-06

5.  Cyclophosphamide and epirubicin induce high apoptosis in microglia cells while epirubicin provokes DNA damage and microglial activation at sub-lethal concentrations.

Authors:  Rafael de la Hoz-Camacho; Ana Luisa Rivera-Lazarín; Jose Manuel Vázquez-Guillen; Diana Caballero-Hernández; Edgar Mendoza-Gamboa; Ana Carolina Martínez-Torres; Cristina Rodríguez-Padilla
Journal:  EXCLI J       Date:  2022-01-10       Impact factor: 4.068

6.  Exercise protocols: The gap between preclinical and clinical exercise oncology studies.

Authors:  Mahmoud Delphan; Neda Delfan; Daniel West; Maryam Delfan
Journal:  Metabol Open       Date:  2022-01-22

7.  Chemotherapy exacerbates ovarian cancer cell migration and cancer stem cell-like characteristics through GLI1.

Authors:  Yawei Zhao; Meihui He; Lianzhi Cui; Mohan Gao; Min Zhang; Fengli Yue; Tongfei Shi; Xuehan Yang; Yue Pan; Xiao Zheng; Yong Jia; Dan Shao; Jing Li; Kan He; Li Chen
Journal:  Br J Cancer       Date:  2020-04-03       Impact factor: 7.640

Review 8.  Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Maryam Omran; Elizabeth K Belcher; Nimish A Mohile; Shelli R Kesler; Michelle C Janelsins; Andrea G Hohmann; Ian R Kleckner
Journal:  Front Mol Biosci       Date:  2021-06-11

9.  Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy.

Authors:  Ian R Kleckner; Todd A Jusko; Eva Culakova; Kaitlin Chung; Amber S Kleckner; Matthew Asare; Julia E Inglis; Kah Poh Loh; Luke J Peppone; Jessica Miller; Marianne Melnik; Samer Kasbari; Deborah Ossip; Karen M Mustian
Journal:  Breast Cancer Res Treat       Date:  2021-06-30       Impact factor: 4.624

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.